Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil
Autore:
Mancia, G; Grassi, G;
Indirizzi:
Univ Milano Bicocca, Osped San Gerardo, Med Clin, Dipartimento Med, I-20052 Milan, Italy Univ Milano Bicocca Milan Italy I-20052 imento Med, I-20052 Milan, Italy
Titolo Testata:
JOURNAL OF HUMAN HYPERTENSION
, volume: 14, anno: 2000, supplemento:, 2
pagine: S3 - S10
SICI:
0950-9240(200010)14:<S3:TROAIR>2.0.ZU;2-0
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY HEART-DISEASE; ISOLATED SYSTOLIC HYPERTENSION; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE; RANDOMIZED TRIAL; DOUBLE-BLIND; ANTIHYPERTENSIVE TREATMENT; CARDIOVASCULAR MORTALITY; ACTIVE TREATMENT; RISK ASSESSMENT;
Keywords:
angiotensin II receptor antagonist; WHO-ISH guidelines; candesartan cilexetil; hypertension;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
65
Recensione:
Indirizzi per estratti:
Indirizzo: Mancia, G Univ Milano Bicocca, Osped San Gerardo, Med Clin, Dipartimento Med, Via Donizetti 106, I-20052 Milan, Italy Univ Milano Bicocca Via Donizetti 106 Milan Italy I-20052 Italy
Citazione:
G. Mancia e G. Grassi, "The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil", J HUM HYPER, 14, 2000, pp. S3-S10

Abstract

The prevention and treatment of hypertension both from the viewpoint of individual patient care and in terms of population health presents a considerable challenge to the medical profession. To assist in meeting this challenge, various bodies have produced guidelines for the management of hypertension during the past 30 years. The aim of this article is to review the recommendations of the most recent of these - the 1999 WHO-ISM guidelines - as well as previous similar documents, including the earlier 1993 WHO-ISM guidelines and the US Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure, and to outline the supportive evidence that has contributed to their formulation, Moreover, the 1999 guidelines have added a new class of antihypertensive drugs, the angiotensin II receptor antagonists, to the armamentarium of therapeutic agents recommendedfor the early treatment of hypertension. Particular attention will be paidin this paper to the role of these agents in hypertension, focusing on candesartan cilexetil as a representative of its class.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 08:26:16